Canadian Bioceutical’s MMPR Application Moving Forward

Canadian Bioceutical Corp. (TSXV:BCC) announced that its subsidiary’s application under Health Canada’s Marijuana for Medical Purposes Regulations (MMPR) is moving forward. The subsidiary, called BioCannabis Products Ltd., filed the application this past January.

As quoted in the press release:

As of April 5, 2015, BioCannabis had received only two minor requests for more information including sample copies of the more critical SOP documents. These documents had been prepared for the company by its management working in co-operation with an outside consultant and with the assistance of Quality Control Laboratories Inc. BioCannabis has been officially informed by Health Canada that its application has progressed to the Enhanced Security Clearance phase. BioCannabis will continue to work with Health Canada to complete and fulfill any additional steps required as it moves through the security clearance phase of the application.

BCC continues to invest considerable management attention and funds in its planned expansion into medical marijuana production as well as towards the development of both cannabis-based and conventional nutraceutical products for both the Canadian and export markets.

Click here to read the full Canadian Bioceutical Corp. (TSXV:BCC) press release.